Scholars Central

CommentaryPublished 22 Aug 2020

Diabetes and Covid-19 Pandemic-A T1 Patient Perspective

Authors: Derek C Beatty

Journal of Diabetes & Metabolism

Volume 11 · Issue 8 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

How might we successfully treat diabetes patients who become seriously ill and hospitalised sufffering from Coronavirus and requiring ventillator breathing assistance? Coronavirus, Covid-19 is the most feared pandemic ever experienced on a global scale with dramatic morbidity and is challenging to treat and overcome. Media reports suggest that 25% of patients who die from Coronavirus are elderly and have an underlying health condition, often diabetes. Could inhaled therapy drug treatment delivered to Critical Care Patients with the Multisonic®Infracontrol Nebuliser lead to improved recovery and reduced morbidity?

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Derek C Beatty”